Feng Ruiyun Jiang

7741034, Jun 22, 2010

Sep 28, 2004

10/952251

Ruth Katz - Houston TX, US
Feng Jiang - Houston TX, US

Board of Regents, The University of Texas System - Austin TX

C07H 21/04
C12Q 1/68

435 6, 435 911, 435 912, 536 231, 536 243

Gene probes for specific regions of chromosome 3 (3p21. 3) and chromosome 10 (10q22) have been found to be tools for the diagnosis and prognosis of smoking related cancers such as non-small cell lung cancer (NSCLC). For example, these probes can be used with fluorescence in situ hybridization (FISH), and used to stratify smokers into high and low risk groups, as well as determine a patients susceptibility to the development of smoking related cancers.

8093001, Jan 10, 2012

Apr 15, 2010

12/761134

Ruth Katz - Houston TX, US
Feng Jiang - Houston TX, US

Board of Regents, The University of Texas System - Austin TX

C07H 21/04
C12Q 1/68

435 61, 435 611, 435 614, 435 911, 435 912, 536 231, 536 243

Gene probes for specific regions of chromosome 3 (3p21. 3) and chromosome 10 (10q22) have been found to be tools for the diagnosis and prognosis of smoking related cancers such as non-small cell lung cancer (NSCLC). For example, these probes can be used with fluorescence in situ hybridization (FISH), and used to stratify smokers into high and low risk groups, as well as determine a patients susceptibility to the development of smoking related cancers.

20020081612, Jun 27, 2002

Aug 6, 2001

09/923304

Ruth Katz - Houston TX, US
Feng Jiang - Houston TX, US

Board of Regents, The University of Texas System

C12Q001/68
C07H021/02
C07H021/04

435/006000, 536/023100

Gene probes for specific regions of chromosome 3 (3p21.3) and chromosome 10 (10q22) have been found to be tools for the diagnosis and prognosis of smoking related cancers such as non-small cell lung cancer (NSCLC). For example, these probes can be used with fluorescence in situ hybridization (FISH), and used to stratify smokers into high and low risk groups, as well as determine a patients susceptibility to the development of smoking related cancers.

20070178503, Aug 2, 2007

Dec 19, 2006

11/641008

Feng Jiang - Ellicott City MD, US

C12Q 1/68
C12M 1/34

435006000, 435287200

An in situ genomic DNA chip can be used directly on clinical specimens in situ for detecting, diagnosing and/or predicting diseases, especially diseases characterized by a genetic aberration such as cancers, by simultaneous detection of one or more unique genetic aberrations using one or more multiple specific probes. The present invention offers high sensitivity for detection of such genetic aberrations and, further, has substantial implications for large-scale population-based molecular epidemiologic studies and therapeutic interventions.

20070218480, Sep 20, 2007

Jan 25, 2007

11/627253

Ruth Katz - Houston TX, US
Feng Jiang - Ellicott City MD, US

C12Q 1/68

435006000

Gene probes for specific regions of chromosomes 1, 3, 9, 10 and 17 are now shown to be useful in the diagnosis and prognosis of smoking related cancers such as non-small cell lung cancer (NSCLC). For example, these probes can be used with fluorescence in situ hybridization (FISH), and used to stratify smokers into high and low risk groups, to determine susceptibility to the development of smoking related cancers, to predict cancer progression and treatment efficacy, and to rule out other diseases.

20210150740, May 20, 2021

Nov 14, 2019

16/684540

- Lake Forest CA, US
Feng Jiang - Irvine CA, US

G06T 7/536
B64D 11/00
G02B 27/00
F16M 11/12
G06F 17/13

Disclosed embodiments are directed at devices, methods, and systems for fixing distortions of content displayed on in-flight entertainment (IFE) monitors in a commercial passenger vehicle. An IFE monitor can receive angular measurement data from one or more gyroscope sensors to determine a differential angle of tilt of the IFE monitor. In response to determining that the differential angle of tilt is non-zero, the IFE monitor can detect that content displayed on the IFE monitor is subject to distortion. The IFE monitor can automatically apply a perspective correction to the content displayed on the IFE monitor for fixing the perceived distortion.

20210108269, Apr 15, 2021

Apr 5, 2018

16/603061

- BALTIMORE MD, US
- WASHINGTON DC, US
Feng Jiang - Ellicott City MD, US

C12Q 1/6886
C12Q 1/686

The present invention provides a method of predicting whether a pulmonary nodule in a subject is benign or non-small cell lung cancer, comprising obtaining the results of an assay that measures an expression level of miR205-5p in a plasma sample from the subject; obtaining the results of an assay that measures an expression level of miR126 in a plasma sample from the subject; obtaining the results of an assay that provides a size of the pulmonary nodule in the subject; and calculating a probability value based on the combination of the expression levels of miR205-5p and miR126, and the size of the pulmonary nodule, wherein if the probability value exceeds a specified threshold, the pulmonary nodule is predicted as non-small cell lung cancer.

20210070450, Mar 11, 2021

Sep 5, 2019

16/562335

- Lake Forest CA, US
Feng Jiang - Irvine CA, US
Gary Chen - Rancho Santa Margarita CA, US
Vic Wu - Irvine CA, US
Xinyu Li - Irvine CA, US

B64D 11/06
B64D 11/00
B60N 3/00

In-vehicle entertainment (WE) monitor systems can be reconfigurable and modular to improve heat dissipation characteristics and to enable separate removal or installation of one or more parts within the WE monitor system without affecting the rest of the IVE monitor system. A modular system for providing in-vehicle entertainment to passengers on a commercial passenger vehicle includes a main housing, a peripheral housing, and a display panel that are separately removable or installable. A main printed circuit board (PCB) in the main housing is electrically connected to a secondary PCB in the peripheral housing via the first data cable and the secondary PCB is electrically connected to the display panel via the second data cable in a series configuration.